Certara Investor Relations Material
Latest events
Q3 2024
Certara
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Certara Inc
Access all reports
Certara Inc. is a life sciences technology company that provides software and services to accelerate drug development and regulatory approval processes. The company specializes in biosimulation, a technology that uses virtual models to predict how drugs behave in the human body, helping pharmaceutical companies optimize clinical trials and drug development strategies. Certara’s offerings support decision-making throughout the drug development lifecycle, from discovery through post-market stages, across a range of therapeutic areas. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Certara Inc
Q3 2024
Certara Inc
Q1 2024
Certara Inc
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
CERT
Country
🇺🇸 United States